纳米技术启用针对癌症治疗药物的向蛋白质降解
Wutong Zhao1, Yongbin Jiang2, Xiufen Li3
1CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
|December 12, 2024
概括
向性蛋白质降解 (TPD) 提供了一种新的治疗方法,利用像PROTACs这样的技术向以前无法治疗的蛋白质. 新兴的方法和纳米传递系统正在改善TPD.
科学领域:
- 生物化学和分子生物学
- 药理学和治疗学 药理学和治疗学
- 生物技术和药物开发
背景情况:
- 向蛋白降解 (TPD) 是一种具有重大潜力的创新治疗策略.
- 现有的药物针对许多与疾病相关的蛋白质,但一些高价值的点,如c-Myc和Ras仍然是不可抗药的.
- 针对蛋白质分解的仿真体 (PROTACs) 已经有了先进的TPD,可以针对以前无法访问的网站.
研究的目的:
- 审查针对性蛋白质降解 (TPD) 技术的最新进展.
- 强调TPD的应用和好处,特别是在癌症治疗中.
- 提供关于TPD未来发展的前性观点.
主要方法:
- 对针对性蛋白质降解的最新科学文献的综述.
- 对新兴TPD模式的分析,包括分子,LYTAC,ATTEC和AbTAC.
- 检查纳米传递系统,以提高TPD的有效性和安全性.
主要成果:
- 包括PROTAC在内的TPD技术扩大了基于蛋白质的药物的治疗视野.
- 生物可用性和不良影响等挑战正在通过新的TPD模式和传递系统得到解决.
- 在各种癌症疗法中,TPD显示出显著的承诺和应用.
结论:
- 在TPD的进步,包括新的模式和交付系统,正在克服以前的局限性.
- 对于未来的治疗应用,特别是瘤学,TPD具有很大的前景.
- 持续的研究和开发对于实现向蛋白质降解的全部潜力至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Regulated Protein Degradation
2.5K
2.5K
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K


